146 related articles for article (PubMed ID: 2404373)
1. Pharmacology of the fluoroquinolones.
Scully BE
Urology; 1990 Jan; 35(1 Suppl):8-10. PubMed ID: 2404373
[No Abstract] [Full Text] [Related]
2. Two new fluoroquinolones.
Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
[No Abstract] [Full Text] [Related]
3. In vitro sensitivities of urinary tract pathogens to lomefloxacin and five other antimicrobial agents.
Peddie BA
N Z Med J; 1989 Jun; 102(869):298. PubMed ID: 2733911
[No Abstract] [Full Text] [Related]
4. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
[No Abstract] [Full Text] [Related]
5. Therapy of urinary tract infections in the elderly: role of fluoroquinolones.
Sant GR; Wainstein M
Urology; 1990 Jan; 35(1 Suppl):19-21. PubMed ID: 2404371
[No Abstract] [Full Text] [Related]
6. Quinolones for short-term treatment of uncomplicated urinary tract infection.
Kadiri S; Ajayi SO; Toki RA
East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolones.
Molavi A
Am Fam Physician; 1988 May; 37(5):279-84. PubMed ID: 3284309
[No Abstract] [Full Text] [Related]
8. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
9. [The clinical and microbiological study of the preparation perfloxacin in treating urologic infections].
Dragiev D; Savov E; Lilov A; Tsenova Z; Saltirov I; Atanasova I
Khirurgiia (Sofiia); 1993; 46(4):49-51. PubMed ID: 8041098
[TBL] [Abstract][Full Text] [Related]
10. [Quinolones: new synthetic antimicrobial agents].
Lopes HV
AMB Rev Assoc Med Bras; 1988; 34(2):54-60. PubMed ID: 3072599
[No Abstract] [Full Text] [Related]
11. The role of the fluoroquinolones in primary care practice.
Harding GK
Clin Invest Med; 1989 Feb; 12(1):71-3. PubMed ID: 2920484
[No Abstract] [Full Text] [Related]
12. Lomefloxacin sensitivities.
Smith JM; Hashmi ZS
N Z Med J; 1990 Jun; 103(891):277-8. PubMed ID: 2356052
[No Abstract] [Full Text] [Related]
13. Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.
Wolfson JS; Hooper DC
Antimicrob Agents Chemother; 1989 Oct; 33(10):1655-61. PubMed ID: 2686545
[No Abstract] [Full Text] [Related]
14. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
15. Laboratory and clinical study of T-3761, a new fluoroquinolone, in urinary tract infection.
Suzuki K; Horiba Y; Ishikawa K; Katoh S; Naide Y; Yanaoka L; Andoh S
Drugs; 1995; 49 Suppl 2():379-81. PubMed ID: 8549368
[No Abstract] [Full Text] [Related]
16. Lomefloxacin sensitivities.
Smith JM; Hashmi ZS
N Z Med J; 1989 Jul; 102(872):391. PubMed ID: 2797570
[No Abstract] [Full Text] [Related]
17. Breakpoint determination: rufloxacin.
Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):574-5. PubMed ID: 8404928
[No Abstract] [Full Text] [Related]
18. Fluoroquinolones: how to use (but not overuse) these antibiotics.
Sable CA; Scheld WM
Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
[TBL] [Abstract][Full Text] [Related]
19. Temafloxacin vs ciprofloxacin for UTI.
Ganiats TG; Norcross WA
J Fam Pract; 1992 Jul; 35(1):14, 16, 18. PubMed ID: 1319461
[No Abstract] [Full Text] [Related]
20. Fluoroquinolone treatment of urinary tract infections.
Urology; 1990 Jan; 35(1 Suppl):1-24. PubMed ID: 2296831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
